April 30, 2018

Brian Koss wins Miltenyi Biotec’s Immuno-Oncology Innovation Award

Brian Koss is the official winner of Miltenyi Biotec’s Immuno-Oncology Innovation Award! There were well over 100 applicants for the award, but Brian’s abstract and scientific endeavors stood out amongst the rest. Brian received paid registration, airfare and hotel accommodations to this year’s American Association for Cancer Research conference in Chicago, as well as 2000 euros worth of reagents to help advance his research


Brian Koss is a third year PhD student working in the laboratory of Dr. Alan Tackett.  Brian’s research focuses on identifying new approaches to combat the metabolic suppression of an immune response in solid tumors. More specifically, Brian’s works aims to mechanistically define epigenetically controlled metabolic stress responses during tumor infiltration. The identification of these mechanisms and demonstration of proof of principle therapies will set the stage for the next generation of cellular therapies.